Emerging data from the UK is generating significant buzz surrounding a potential synergy between high-dose Nicotinamide Adenine Dinucleotide supplementation – specifically doses of 1000mg – and the novel treatment Retatrutide. Preliminary observations suggest that this novel approach might offer